COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Tuesday, 19 May 2020
https://www.barrons.com/articles/a-covid-19-vaccine-could-be-worth-billions-for-moderna-and-its-rivals-51589902769.
Moderna has a $30 Billion market valuation and has not sold one thing. The price of the vaccine (if there is a vaccine) could cost up to $200 a dose. That would be a very big business. This is back to the Dot Com days of the 90's.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment